TRCT
APUS

Tower Research Capital (TRC)’s Apimeds Pharmaceuticals US, Inc. APUS Stock Holding History

Tower Research Capital (TRC)’s Portfolio APUS Stock Details APUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$5.55K Buy
+3,151
New +$5.55K ﹤0.01% 4175